• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国人专用的放射性碘内照射剂量系数。

Radioiodine internal dose coefficients specific for Koreans.

作者信息

Kwon Tae-Eun, Chung Yoonsun, Lee Choonsik

机构信息

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, United States of America.

Department of Nuclear Engineering, Hanyang University, Seoul, 04763, South Korea.

出版信息

Nucl Eng Technol. 2024 Jul;56(7):2732-2739. doi: 10.1016/j.net.2024.02.034. Epub 2024 Feb 19.

DOI:10.1016/j.net.2024.02.034
PMID:39206248
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11356768/
Abstract

This study developed internal dose coefficients for radioiodine, tailored to the Korean population, by incorporating the Korean biokinetic model along with the Korean S values. The observed differences in dose coefficients for Koreans compared to the International Commission on Radiological Protection (ICRP) reference values noticeably varied depending on physical half-lives of iodine isotopes. For longer-lived isotopes such as I-125 and I-129, significant differences in thyroid dose coefficients were observed, with ratios (Korean/ICRP) from 0.30 to 0.55, indicating that actual doses for Koreans can be considerably lower than those evaluated based on the ICRP data. However, for short-lived iodine isotopes, such as I-131, the thyroid dose coefficients were comparable to the ICRP reference values (ratio=0.95-0.98). These comparable dose coefficients resulted from the lower thyroidal iodine uptake in the Korean model being almost entirely offset by the higher thyroid self-absorption S values in the Korean phantoms. Additionally, this study delves into the substantial differences in absorbed dose coefficients for non-thyroidal regions and effective dose coefficients, which arose not only from physiological/anatomical variability but also technical differences in phantom design. The use of Korean-specific dose coefficients is advisable particularly in scenarios predicting elevated doses, yielding a more precise and clinically relevant dose assessment.

摘要

本研究通过纳入韩国生物动力学模型以及韩国的S值,开发了针对韩国人群的放射性碘内照射剂量系数。与国际放射防护委员会(ICRP)参考值相比,韩国人剂量系数的观察差异因碘同位素的物理半衰期而异。对于寿命较长的同位素,如I - 125和I - 129,甲状腺剂量系数存在显著差异,比率(韩国/ICRP)为0.30至0.55,这表明韩国人的实际剂量可能远低于基于ICRP数据评估的剂量。然而,对于短寿命碘同位素,如I - 131,甲状腺剂量系数与ICRP参考值相当(比率 = 0.95 - 0.98)。这些相当的剂量系数是由于韩国模型中较低的甲状腺碘摄取几乎完全被韩国体模中较高的甲状腺自吸收S值所抵消。此外,本研究深入探讨了非甲状腺区域吸收剂量系数和有效剂量系数的显著差异,这些差异不仅源于生理/解剖学变异性,还源于体模设计的技术差异。在预测剂量升高的情况下,尤其建议使用韩国特定的剂量系数,以进行更精确且与临床相关的剂量评估。

相似文献

1
Radioiodine internal dose coefficients specific for Koreans.韩国人专用的放射性碘内照射剂量系数。
Nucl Eng Technol. 2024 Jul;56(7):2732-2739. doi: 10.1016/j.net.2024.02.034. Epub 2024 Feb 19.
2
Korean-specific biokinetic model for iodine in radiological protection.放射性防护碘的韩国专用生物动力学模型。
J Radiol Prot. 2021 Jun 1;41(2). doi: 10.1088/1361-6498/abd842.
3
Absorbed dose coefficients for adult thyroid cancer patients undergoing radioiodine therapy.成人甲状腺癌患者放射性碘治疗的吸收剂量系数。
J Radiol Prot. 2023 May 25;43(2). doi: 10.1088/1361-6498/acd648.
4
A physiological systems model for iodine for use in radiation protection.用于辐射防护的碘的生理系统模型。
Radiat Res. 2010 Oct;174(4):496-516. doi: 10.1667/RR2243.1.
5
Korean-specific iodine S values for use in internal dosimetry.用于内照射剂量学的韩国特定碘S值。
Nucl Eng Technol. 2023 Dec;55(12):4659-4663. doi: 10.1016/j.net.2023.09.005. Epub 2023 Sep 22.
6
Absorbed dose coefficients for pediatric differentiated thyroid cancer patients undergoing radioiodine therapy.接受放射性碘治疗的小儿分化型甲状腺癌患者的吸收剂量系数。
J Radiol Prot. 2024 Feb 7;44(1). doi: 10.1088/1361-6498/ad1fdc.
7
Evaluation of effective dose conversion coefficients for Korean adults during medical x-ray examinations up to 150 keV through comparison with ICRP Publication 74 and ICRP Publication 116.通过与国际辐射防护委员会第74号出版物和第116号出版物对比,评估韩国成年人在高达150 keV的医用X射线检查期间的有效剂量转换系数。
J Radiol Prot. 2014 Mar;34(1):191-9. doi: 10.1088/0952-4746/34/1/191. Epub 2014 Jan 17.
8
I dose coefficients for a reference population using age-specific models.我使用特定年龄模型为参考人群计算剂量系数。
J Radiol Prot. 2023 Nov 2;43(4). doi: 10.1088/1361-6498/ad04ef.
9
Simulations of radioiodine exposure and protective thyroid blocking in a new biokinetic model of the mother-fetus unit at different pregnancy ages.不同妊娠龄母体-胎儿单位新生物动力学模型中放射性碘暴露和甲状腺保护阻断的模拟。
Arch Toxicol. 2022 Nov;96(11):2947-2965. doi: 10.1007/s00204-022-03331-0. Epub 2022 Aug 4.
10
Organ dose conversion coefficients calculated for Korean pediatric and adult voxel phantoms exposed to external photon fields.针对暴露于外部光子场的韩国儿童和成人体素模型计算的器官剂量转换系数。
J Radiat Prot Res. 2020 Jun;45(2):69-75. doi: 10.14407/jrpr.2020.45.2.69. Epub 2020 Jun 30.

引用本文的文献

1
Korean-specific internal dosimetry data for radioiodine bioassay and evaluation of the dosimetric impact.用于放射性碘生物测定的韩国特定内照射剂量学数据及剂量学影响评估。
Nucl Eng Technol. 2025 Mar;57(3). doi: 10.1016/j.net.2024.10.032. Epub 2024 Oct 16.

本文引用的文献

1
Korean-specific iodine S values for use in internal dosimetry.用于内照射剂量学的韩国特定碘S值。
Nucl Eng Technol. 2023 Dec;55(12):4659-4663. doi: 10.1016/j.net.2023.09.005. Epub 2023 Sep 22.
2
Absorbed dose coefficients for adult thyroid cancer patients undergoing radioiodine therapy.成人甲状腺癌患者放射性碘治疗的吸收剂量系数。
J Radiol Prot. 2023 May 25;43(2). doi: 10.1088/1361-6498/acd648.
3
ICRP Publication 147: Use of Dose Quantities in Radiological Protection.国际放射防护委员会第147号出版物:放射防护中剂量量的使用。
Ann ICRP. 2021 Feb;50(1):9-82. doi: 10.1177/0146645320911864.
4
Korean-specific biokinetic model for iodine in radiological protection.放射性防护碘的韩国专用生物动力学模型。
J Radiol Prot. 2021 Jun 1;41(2). doi: 10.1088/1361-6498/abd842.
5
ICRP Publication 145: Adult Mesh-Type Reference Computational Phantoms.国际放射防护委员会第145号出版物:成人网状型参考计算人体模型。
Ann ICRP. 2020 Oct;49(3):13-201. doi: 10.1177/0146645319893605.
6
INVESTIGATION OF THE INFLUENCE OF THYROID LOCATION ON IODINE-131 S VALUES.甲状腺位置对碘-131 S值影响的研究
Radiat Prot Dosimetry. 2020 Jul 13;189(2):163-171. doi: 10.1093/rpd/ncaa027.
7
Reassessment of Internal Thyroid Doses to 1,080 Children Examined in a Screening Survey after the 2011 Fukushima Nuclear Disaster.福岛核灾难后筛查检测的 1080 名儿童的甲状腺内剂量重新评估。
Health Phys. 2020 Jan;118(1):36-52. doi: 10.1097/HP.0000000000001125.
8
Association of Radioactive Iodine Treatment With Cancer Mortality in Patients With Hyperthyroidism.放射性碘治疗与甲状腺功能亢进症患者癌症死亡率的关联。
JAMA Intern Med. 2019 Aug 1;179(8):1034-1042. doi: 10.1001/jamainternmed.2019.0981.
9
PRACTICAL METHODS FOR INTERNAL DOSE ASSESSMENT FOR RADIOIODINE INTAKE AFTER THYROID BLOCKING: CLASSIFICATION OF DEGREE OF BLOCKAGE AND DETERMINATION OF INSENSITIVE MEASUREMENT POINT.甲状腺阻断后放射性碘摄入内照射剂量评估的实用方法:阻断程度分类及不敏感测量点的确定
Radiat Prot Dosimetry. 2019 Dec 31;187(1):69-76. doi: 10.1093/rpd/ncz139.
10
Internal Dose Assessment after 131I-Iodide Misadministration in a Patient With Incompletely Blocked Thyroid Uptake: Personalized Internal Dose Assessment by Estimating Individual-Specific Biokinetics.131I-碘化物误用后患者体内内剂量评估:通过估计个体特异性生物动力学进行个体化内剂量评估。
Health Phys. 2019 Jun;116(6):760-770. doi: 10.1097/HP.0000000000001019.